Similarly, shRNA against KDM5B decreased tumor volume and weight by 60–70% in PDAC mice xenograft, while in combination with gemcitabine, the tumor growth was inhibited much stronger than individually used shKDM5B or gemcitabine [195]. This evidence concerns the gene KDM5B and neoplasm.